| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Health Care
| Amgen is actively advancing its product lines and continues to invest in late-stage development programs, indicating a strong potential for future growth in therapeutic offerings. However, challenges such as clinical trial failures and generational drug development obstacles loom large, negatively affecting investor confidence and highlighting difficulties in meeting clinical benchmarks. While recent innovations and research present promising advancements, the overarching issues in trial success present significant hurdles. Balancing these factors will be crucial for sustained development and market success. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -3.5 is extremely bearish. The market sentiment at -0.9 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. AMGN is likely to move down since both trend sentiment and market sentiment are negative. The positive sentiment force for sector is at 0.4, and the negative at -1.3 on 2026-09-11. The forces of Stock Price Trend (-3.5), Valuation Sentiment (-3.2), Sector Price Trend (-1), Market Risk Appetite (-0.4), and Sentiment towards Fundamentals (-0.3) will drive down the price. The forces of Price Level Sentiment (1), and Option Sentiment (1.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| AMGN | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 | 0%(0%) | 377.96 | 5.65% | -6 | 20 | 20 | -1.25% | -1.4% | -3.5 | -0.5 | 1.3% | -0.9 | Short | 70% | -0.3 | 4 |
| 2026-09-10 | 0%(0%) | 382.74 | 4.83% | -11 | 25 | 12 | -2.33% | -1.38% | -3.3 | -0.4 | 1.3% | -0.8 | Short | 70% | -0.8 | -1 |
| 2026-09-09 | 0%(0%) | 391.86 | 3.99% | -10 | 25 | 30 | -0% | -1.15% | -2.6 | -0.7 | 4.5% | -0.5 | Short | 70% | -2 | -1 |
| 2026-09-08 | 0%(0%) | 391.86 | 3.48% | -21 | 36 | 5 | -10.41% | -1.23% | -2.4 | -1.7 | 5.2% | -0.3 | Short | 60% | -2.3 | -6.3 |
| 2026-09-07 | 0%(0%) | 0.3 | -1.7 | 0.4 | -0.7 | -1 | ||||||||||
| 2026-09-06 | 0%(0%) | 0.3 | -1.7 | 0.7 | 1.1 | -1 | ||||||||||
| 2026-09-05 | 0%(0%) | 0.3 | -1.7 | 0.7 | 1.1 | -1 | ||||||||||
| 2026-09-04 | 0%(0%) | 437.4 | 2.5% | 63 | 62 | 40 | -1.48% | -0.05% | 0.3 | -0.1 | 0.6% | 1.3 | Short | 55% | 1.9 | -1 |
| 2026-09-03 | 0%(0%) | 443.96 | 2.64% | 79 | 69 | 76 | 0.23% | 0.23% | 0.9 | 0.3 | 0.6% | 1.6 | Long | 55% | 1.8 | -1 |
| 2026-09-02 | 0%(0%) | 442.93 | 2.84% | 79 | 66 | 79 | 1.12% | 0.02% | 0.5 | 0.6 | 0.9% | 1.4 | Long | 55% | 2.6 | -1 |
| Short is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very weak. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-09-11 17:04:16 Amgen's established market presence and financial strength provide it with competitive advantages over emerging biotech firms. |
| 2026-09-11 17:04:16 The competitive landscape is highlighted as Amgen is compared against other biotech firms, reflecting the need for strategic positioning. |
| 2026-09-11 17:04:16 Amgen is focusing on growth in its product lines and late-stage development programs, suggesting robust future potential. |
| 2026-09-11 17:04:16 Amgen has shown strong earnings capabilities, with significant cash flow generation and stable revenues noted in discussions. |
| 2026-09-11 17:04:16 Amgen's stock performance has been variable, with recent declines causing concern among investors despite solid earnings reports. |
| 2026-09-11 13:47:08 The articles discuss the potential impact of innovative cancer drug launches from Revolution Medicines and CRISPR Therapeutics, emphasizing the transformative possibilities of their research. |
| 2026-09-11 13:47:08 Both articles assess the potential for investment in Amgen compared to its competitors, highlighting the importance of revenue generation and profitability for stock performance. |
| 2026-09-11 13:47:08 The articles contrast the financial stability of Amgen, which is profitable and paying dividends, with the high-risk, high-reward approach of Revolution Medicines and CRISPR Therapeutics, which are burning cash for innovative breakthroughs. |